Jeff Talbot of Roseman University of Health Sciences discusses how Las Vegas is positioning itself as a growing life sciences hub by offering cost-effective laboratory space, access to capital, and a flexible environment for biotech startups and emerging companies.
Editor’s note:This interview has been lightly edited for brevity and clarity.
As biopharma companies seek alternatives to high-cost coastal markets, emerging regions are positioning themselves as attractive destinations for research, development, and manufacturing. At BIO 2026, BioPharm International caught up with Jeff Talbot, vice president for research and dean of the College of Graduate Studies at Roseman University of Health Sciences, to discuss the university’s efforts to build a life sciences innovation hub in Las Vegas, the advantages of a distributed biotech model, and why startups are increasingly looking beyond traditional industry centers…